These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4223693)

  • 21. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 22. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of heparin, epsilon aminocaproic acid, or both agents to prevent increased fibrinogen levels after endotoxin in rabbits.
    Logan LJ; Rapaport SI; Kuefler P
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):321-3. PubMed ID: 4566763
    [No Abstract]   [Full Text] [Related]  

  • 24. [INDICATIONS AND HANDLING OF FIBRINOLYTIC ENZYME INHIBITORS].
    BERNARD J; BOUSSER J; DREYFUS B; HAMBURGER J; PEQUIGNOT H
    Presse Med (1893); 1964 Jan; 72():167-9. PubMed ID: 14106785
    [No Abstract]   [Full Text] [Related]  

  • 25. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood coagulating properties of immobilized proteases].
    Zubairov DM; Zinkevich OD
    Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinolytic proteases in snake venoms.
    Kornalik F; Stýblová Z
    Experientia; 1967 Dec; 23(12):999-1000. PubMed ID: 4229613
    [No Abstract]   [Full Text] [Related]  

  • 28. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 29. Stimulating effect on tissue-type plasminogen activator--a new and sensitive indicator of denatured fibrinogen.
    Haddeland U; Bennick A; Brosstad F
    Thromb Res; 1995 Feb; 77(4):329-36. PubMed ID: 7740524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen clottability and fibrin formation.
    Alexander B
    Thromb Diath Haemorrh Suppl; 1966; 20():191-200. PubMed ID: 4226518
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of bile salts on some coagulation components and related enzymes.
    Engel AM; Alexander B
    Thromb Diath Haemorrh; 1972 Jul; 27(3):594-609. PubMed ID: 4268053
    [No Abstract]   [Full Text] [Related]  

  • 34. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of a contaminant in thrombin in the human plasmin assay system.
    CLIFFTON EE; SIEGEL M
    J Gen Physiol; 1957 Jan; 40(3):377-92. PubMed ID: 13398570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of epsilon-aminocaproic acid on streptokinase-induced thrombolysis].
    Hiemeyer V; Rasche H
    Klin Wochenschr; 1965 Sep; 43(17):930-4. PubMed ID: 5863559
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
    Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R
    Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The destruction of factor VIII clotting activity by thrombin and plasmin.
    Denson KW; Redman CW
    Thromb Res; 1980 May 1-15; 18(3-4):547-9. PubMed ID: 6447928
    [No Abstract]   [Full Text] [Related]  

  • 39. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of endotoxin on clotting mechanism. III. On the relationship between hypercoagulability, plasminogen activator activity, and antithrombin activity.
    GANS H; HANSON M; KRIVIT W
    Surgery; 1963 Jun; 53():792-6. PubMed ID: 13946415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.